Success after a century of failures: Inside Moderna and Merck's cancer vaccine breakthrough
Cancer vaccine from Moderna, Merck shows promise in late-stage trial; both stocks soar
| FILE PHOTO: Moderna CEO Stephane Bancel speaks at the Boston College Chief Executives Club luncheon in Boston, Massachusetts, U.S., April 4, 2022. REUTERS/Katherine Taylor/File Photo |